The purpose of this study is to evaluate the pharmacokinetics, safety, and tolerability of
new liquid formulations of tricaprilin, with the aim of finding a suitable formulation to
advance in development. This is a three-part, part-randomised study that include single-dose,
food effect, and titration tolerability in up to 80 healthy participants.